Archive for November, 2009

Swine flu drives over-the-counter medicine sales across borders

Autumn has arrived in the northern hemisphere and with shades of yellow and orange comes a less-welcome visitor: cold and flu season. Made worse this year by the H1N1 (swine flu) pandemic, people around the world are flocking to drugstores and supermarkets to stock up on over-the-counter (OTC) medicine, says market research firm Mintel.

Mintel’s Global Market Navigator (GMN) predicts Americans will cough up a total $3.6 billion on cold, cough and throat remedies this year, 1.7% more than during 2008. In Britain, people could fork over an eye-watering £428 million by year’s end, a 4.2% increase over 2008.

Diana Nhan, senior market analyst for Mintel GMN, comments on how swine flu could impact OTC medicine sales this year:

“The US cold, cough and throat remedy market saw a 13.4% spike in sales during 2005, when the avian flu dominated media stories. Already, swine flu has received equivalent media exposure, and many Americans are worried about the virus. I wouldn’t be surprised to see a similar trend-busting increase in US cold, cough and throat remedy sales for 2009 and the early part of 2010.”

In total, Americans will spend more than $32 billion on OTC pharmaceuticals this year, while Britons dedicate £2.6 billion towards alleviating symptoms. The Chinese are expected to spend over ¥58 billion, while Russians bear out cold weather in the name of $3.4 billion. Mintel GMN expects all four countries to see sales increases for OTC medication in 2010.

Americans dedicate more funds towards treating the sniffles than people in the UK, China or Russia. In the US, OTC medicine sales account for 0.22% of GDP, compared to 0.20% in Russia and approximately 0.17% in the UK and China.

Leave a Comment

Study Illustrates How Poor Health Can Impact Current and Future Financial Concerns

While one might anticipate that poor health takes a financial toll on employees, new findings released today from MetLife’s 7th Annual Employee Benefits Trends Study help define what those financial consequences can be, both short- and long-term. The MetLife study found that working Americans who say they are in fair or poor health are also more likely to be in worse financial shape than their healthier counterparts. For example:

  • 59% of people who assess their medical health as fair or poor say they live paycheck to paycheck, compared to 34% of people in very good or excellent health.
  • 70% of people who assess their medical health as fair or poor are very concerned about making ends meet, compared to 52% of people in very good or excellent health.
  • 76% of people who assess their medical health as fair or poor are very concerned about affording health care in retirement, compared to 57% of people in very good or excellent health.

“Fortunately, employers are increasingly recognizing the value to all stakeholders of a healthy workforce and viewing wellness programs as an investment to help address their business objectives of employee retention and productivity while simultaneously controlling costs,” says Ronald Leopold, M.D., vice president, U.S. Business, MetLife. “While medical coverage is an important component of a financial safety net, health insurance is not health assurance. In fact, the MetLife study found that employees who assess their health as fair or poor have medical coverage through the workplace at nearly the same rates of those with very good or excellent health.”

The number of employers offering wellness programs in the workplace is growing, but at a slower rate than one might anticipate given that the vast majority of U.S. employers (94%) agree that wellness programs can be at least somewhat effective in reducing medical costs. Only one-third (33%) of employers offer a wellness program to their employees, up from about one-fourth (27%) in 2005. In addition, only a little more than half (57%) of larger employers, those with 500 or more employees, have implemented a workplace wellness program, although this is an increase from 46% in 2005.

Employees appear to appreciate the value wellness programs provide. Nearly half of all employees (46%) say they avail themselves of their employer’s wellness program when offered. The top motivator for employees’ participation? They want “good health,” cited by nearly three-quarters of wellness program participants. Interestingly, the second greatest motivating factor varies by gender – men cite the financial incentives their employer provides while women say they want to minimize medical expenses.

“Good health is its own reward, and a strong inducement for employees to take advantage of workplace wellness programs,” adds Dr. Leopold.

Leave a Comment

Surgeon Implants High-Tech Artificial Bone in Three-Year-Old’s Arm

When little Mark Blinder was diagnosed with a rare bone cancer, doctors at Lucile Packard Children’s Hospital gave his parents three agonizing options: amputate the affected arm at the shoulder, irradiate the tumor and risk a second malignancy, or try a limb-preserving surgery that had never been attempted in a toddler.

Nearly a year later, Mark, now four, is thriving with a surgically implanted artificial humerus inside his cancer-free right arm. He’s believed to be the first small child ever to receive a high-tech, telescoping prosthesis to replace the entire upper arm bone.

“This was a very unusual and challenging case,” said orthopedic surgeon Lawrence Rinsky, MD, who implanted the custom-made, one-of-a-kind artificial bone he also helped design.

“Little children with humerus tumors have very few limb-sparing options,” added Neyssa Marina, MD, the pediatric oncologist who oversaw Mark’s chemotherapy before and after surgery.

Rinsky and Marina aimed for a first-of-its-kind treatment that would cure Mark’s cancer, preserve his hand and allow his arm to keep growing. Designing and implanting an artificial humerus bone that would grow with Mark had obvious advantages over radiation, which would have killed the bone’s growth plates, or amputation. But the unconventional strategy came with no guarantees.

The prosthetic bone had to be small enough to fit in a three-year-old’s arm, strong enough to last a lifetime, and expandable, to allow for Mark’s growth. Balancing these demands presented a significant engineering challenge. On top of that, because Mark’s entire humerus had to be removed, the prosthesis could attach only to soft tissue. Most bone prosthetics replace half of a bone and are cemented to healthy bone; Rinsky had to find another way to hook up this implant. Even when the design was finalized with Indiana-based prosthetic manufacturer Biomet, Inc., Rinsky wasn’t sure the surgery would work.

Mark’s parents, Alla Ostrovskaya and Gene Blinder, felt trepidation, too.

“It was hard because if we had chosen just radiation, no surgery, that would not have been as physically painful for him,” Alla said. Surgery seemed the best choice for Mark’s long-term well-being.

They first realized something was wrong when, in April 2008, Mark complained of severe pain in his right arm, hand and wrist. After his July 2008 diagnosis with a rare bone tumor called Ewing’s sarcoma, Mark began chemotherapy. The medications helped: the pain subsided and Mark began using his arm normally. But chemotherapy alone wouldn’t vanquish the tumor.

So, early on December 4, 2008, Mark was wheeled into the operating room. Rinsky and his team, encased in space suit-like outfits to reduce infection risk, worked with utmost care. “The surgery involved taking out the entire bone without touching it,” Rinsky said. The bone had cancer cells on its surface, which could easily have spread to surrounding healthy tissue. “It was like carving out a peach pit without ever touching the pit, staying in the pulp.”

Once the cancerous bone was out, Rinsky implanted the artificial bone. The prosthesis had a piece of Dacron fabric at the top, which he sewed to soft tissue in Mark’s shoulder. At the elbow, Rinsky saved Mark’s ligaments and placed those around the prosthesis as best he could. Then he started sewing up Mark’s arm. Luckily, the incision closed.

“Dr. Rinsky came out of the operating room and said, ‘The prosthesis fit perfectly fine, he is doing great,’” remembered Gene.

Soon, there was more good news: Mark’s tumor was confined to the bone that had been removed, and its malignant cells were dead, killed by chemotherapy. He spent a month healing from surgery, then received more chemotherapy to reduce the chance the cancer would return. He’ll have three to four minor surgeries over the next several years, in which Rinsky will make a small incision at the shoulder and use a few turns of a screwdriver to lengthen the implant as Mark grows.

Gene and Alla knew Mark was truly feeling better when he began getting into mischief again. In June, just before his final round of chemotherapy, he was playing “strongman” and accidentally dropped a 2-pound dumbbell on his head. “It was pure four-year-old,” said Rinsky with a grin. (A CT scan showed no harm had been done by the bump.) “He is a very spunky kid,” said Marina.

Meanwhile, Mark is gradually re-learning to use his right hand and arm. He’s moving his right wrist and fingers, can pick up small objects, and is receiving physiotherapy to rebuild strength and flexibility in his elbow and shoulder. Although Mark won’t ever regain full function in these joints, he’s using the arm more each day, Alla said. As he often tells his family, “I have a special arm.”

Leave a Comment